4
Changes in Ownership
Xenon Pharmaceuticals Inc. Filed Acc 0001209191-20-056222
Director acquired 2,057 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PATOU GARY · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-10-28 | Exercise or conversion : show line 1 in the form | +2,057 | $3.76 | $7,734 | 23,573 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-10-28 | Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) | −2,057 | 0 | D |
Loading xslF345X03/doc4.xml…